Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics (PRQR) Revenue (2021 - 2025)

Historic Revenue for ProQR Therapeutics (PRQR) over the last 5 years, with Q3 2025 value amounting to $3.4 million.

  • ProQR Therapeutics' Revenue fell 2016.94% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.0 million, marking a year-over-year decrease of 1203.49%. This contributed to the annual value of $20.5 million for FY2024, which is 19038.76% up from last year.
  • As of Q3 2025, ProQR Therapeutics' Revenue stood at $3.4 million, which was down 2016.94% from $4.3 million recorded in Q2 2025.
  • ProQR Therapeutics' 5-year Revenue high stood at $6.8 million for Q2 2024, and its period low was $170079.3 during Q1 2021.
  • Over the past 5 years, ProQR Therapeutics' median Revenue value was $1.3 million (recorded in 2023), while the average stood at $2.4 million.
  • Per our database at Business Quant, ProQR Therapeutics' Revenue skyrocketed by 64567.67% in 2022 and then crashed by 4456.59% in 2023.
  • ProQR Therapeutics' Revenue (Quarter) stood at $273409.1 in 2021, then surged by 168.67% to $734578.1 in 2022, then soared by 381.01% to $3.5 million in 2023, then surged by 30.26% to $4.6 million in 2024, then dropped by 26.79% to $3.4 million in 2025.
  • Its Revenue was $3.4 million in Q3 2025, compared to $4.3 million in Q2 2025 and $4.8 million in Q1 2025.